
MIMESIS SRL is an innovative startup that applies computational models to the pharmaceutical/nutraceutical sector, allowing the simulation of phenomena of a structural-chemical-biological nature. Mimesis offers the first generation of “In Silico” solutions to the biomedical industry and pharmaceutical companies to reduce time and costs in the research and development process of medicinal products. Mimesis cares about ethics since the solutions adopted do not require the use of humans, leading to a potential reduction of the number of patients who take part in clinical studies. The estimated cost required for the approval of a new drug by regulatory agencies (EMA and FDA) varies between 2 and 3 billion dollars and it takes at least 10 years before the drug arrives on the market.
Location: Italy, Sicily, Catania
Employees: 1-10
Founded date: 2020
Mentions in press and media 1
Date | Title | Description |
16.11.2023 | Which Italian Product Research Startups Are Revolutionizing the Industry? | Italy, known for its rich culture and history, is also rapidly becoming a hub for technology and innovation. With a growing startup culture, Italy is proving to be a place where new ideas in product research are flourishing. From environmen... |